High levels of DHT may reduce diabetes risk

The title says it all, as the study is quite clear. DHT “…was most consistently associated with a lower level of insulin resistance and lower risk of incident diabetes” in the words of the study’s lead author. The current darling of “aging/obese male” treatments – testosterone (T) – was not associated with lower insulin resistance … Read more

Aspirin – a new osteoporosis drug

A study published almost a decade ago made the bold claim that aspirin may be a novel drug for osteoporosis. https://www.ncbi.nlm.nih.gov/pubmed/21600123 However, the study did not get much traction and was in fact mocked by medical professionals since mainstream medicine considered the known anti-estrogenic effects of aspirin to be incompatible with a bone-protective effect. The … Read more

Progesterone may treat diabetes, obesity, and metabolic syndrome

Interesting new study, which adds more to the already existing mountain of evidence for the benefit of progesterone in a variety of conditions of metabolic origin. While the study does not mention any specific doses, it is known that the receptor (PGRMC2) whose activation the study found to be beneficial for diabetes/obesity, is activated by … Read more

Inhibiting aromatase (to lower estrogen) may treat gastric (stomach) cancer

Yet another study demonstrating the causative link between estrogen and a cancer considered to be hormone-independent. Gastric cancer is one of the leading causes of cancer-deaths worldwide, and especially Asian countries. It is considered very hard to treat and most patients are diagnosed at stages when surgery is not a viable option. As such, the … Read more

Drostanolone (a DHT isomer) may treat prostate cancer

The bad news for the DHT-driven theory of prostate cancer just keep piling on. There have been at least 3 human trials in the last 5 years demonstrating that the direct injection of testosterone (T) into the prostate can stop advanced, inoperable prostate cancer. Instead of admitting what is quite obvious at this point – … Read more